FDA Warning Letter — Aparna Pharmaceuticals Private Limited
The FDA took a Warning Letter action against Aparna Pharmaceuticals Private Limited on Aug 8, 2019 (Pyidibhimavaram, Srikakulam, India). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Aparna Pharmaceuticals Private Limited
- Date
- Aug 8, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Pyidibhimavaram, Srikakulam (India)